Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 52,100 KRW
Change Today 0.00 / 0.00%
Volume 124.6K
As of 2:20 AM 10/2/15 All times are local (Market data is delayed by at least 15 minutes).

ilyang pharmaceutical co ltd (007570) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/6/15 - 102,000
52 Week Low
12/17/14 - 23,250
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ILYANG PHARMACEUTICAL CO LTD (007570)

Related News

No related news articles were found.

ilyang pharmaceutical co ltd (007570) Related Businessweek News

No Related Businessweek News Found

ilyang pharmaceutical co ltd (007570) Details

Ilyang Pharamaceutical Co., Ltd. operates as a pharmaceutical company primarily in South Korea. The company offers anticancer, circulatory system, endocrine/metabolism, Cheonjiyang, female hormone, urinary system, ophthalmology, liver disease, digestive system, dermatology, infusion of nutrient, neurology, and respiratory system medicines. It also provides antibiotics, antifungal drugs, anti-inflammatory analgesic drugs, insecticides, and vaccines; and health drinks, daily food, supplements, health food, cosmetics, and beverages. In addition, the company offers pharmaceutical raw materials products, such as aluminum hydroxide gel, dried aluminum hydroxide gel, magnesium hydroxide, magnesium hydroxide gel, aluminum hydroxide-magnesium carbonate co-dried gel, magnesium trisilicate, hydrotalcite, almagate, aluminum phosphate, aluminum phosphate gel, aluminum magnesium metasilicate, aluminum magnesium silicate, aluminum magnesium silicopolydrate(simaldrate), magaldrate, magaldrate wet gel, dihydroxy aluminum sodium carbonate, magnesium carbonate, aluminum magnesium hydroxide(magcerin), synthetic aluminum silicate, and other products. Ilyang Pharamaceutical Co., Ltd. also exports pharmaceutical raw materials and finished products to 14 countries. The company was formerly known as Il-Yang Pharm. Ind. Co. and changed its name to Ilyang Pharamaceutical Co., Ltd. in May 1991. Ilyang Pharamaceutical Co., Ltd. was founded in 1946 and is headquartered in Yongin, South Korea.

ilyang pharmaceutical co ltd (007570) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

ilyang pharmaceutical co ltd (007570) Key Developments

Ilyang Pharmaceutical Co., Ltd to Report Q1, 2016 Results on Jul 28, 2015

Ilyang Pharmaceutical Co., Ltd announced that they will report Q1, 2016 results on Jul 28, 2015

Ilyang Pharmaceutical Co., Ltd, Annual General Meeting, May 30, 2014

Ilyang Pharmaceutical Co., Ltd, Annual General Meeting, May 30, 2014., at 09:00 Korea Standard Time. Location: Headquarters Auditorium. Agenda: To consider audit reports, sales reports; to consider 43rd financial statements (including the statement of retained earnings) ended March 31, 2014; to consider the election of directors; to consider appointment of audit committee; and to consider the approval of director remuneration.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
007570:KS 52,100.00 KRW 0.00

007570 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 007570.
View Industry Companies

Industry Analysis


Industry Average

Valuation 007570 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.8x
Price/Book 4.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 3.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ILYANG PHARMACEUTICAL CO LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at